<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04357301</url>
  </required_header>
  <id_info>
    <org_study_id>P2020/157</org_study_id>
    <nct_id>NCT04357301</nct_id>
  </id_info>
  <brief_title>Tight Closed-loop Systolic Arterial Pressure Control</brief_title>
  <official_title>Tight Systolic Arterial Pressure Control Using a Closed-loop System for Vasopressor Infusion in Patients Undergoing High-risk Abdominal Surgery: A Proof-of-Concept Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Erasme University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Erasme University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this case series is to evaluate the performance of a novel closed-loop&#xD;
      (automated) vasopressor administration system that delivers norepinephrine using feedback&#xD;
      from standard operating room hemodynamic monitoring (EV1000 monitoring device, Edwards&#xD;
      Lifesciences, Irvine, USA).&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In this case series, the investigators will report the percentage of case time in hypotension&#xD;
      (defined as systolic arterial pressure (SAP) &lt; 117mmHg). The target mean arterial pressure&#xD;
      (MAP) will be set at a SAP of 130mmHg in all patients. Definition of Hypotension is target&#xD;
      SAP - 10% (130mmHg - 13 mmHg = 117 mmHg). We will use the same SAP target in all patients&#xD;
      even if we used a modified definition of hypotension from the study of Futier and colleagues&#xD;
      ( JAMA 2017). We won't use a individualized SAP for each patient but the same SAP target in&#xD;
      all patients.&#xD;
&#xD;
      The investigators want to demonstrate that the closed-loop system can prevent hypotension at&#xD;
      this specific set point.&#xD;
&#xD;
      The Investigators have shown the system works well based on a target MAP but not yet using a&#xD;
      target of SAP.&#xD;
&#xD;
      The investigators will test the system in a pilot study of 13 patients undergoing High-risk&#xD;
      abdominal surgery which require the placement of a arterial catheter, the optimization of&#xD;
      fluid therapy and a tight SAP control.&#xD;
&#xD;
      Participants will receive standard patient care in that in no way will their anesthetic or&#xD;
      surgical procedure will be altered as part of the study, with the exception of vasopressor&#xD;
      administration ( automatically delivery instead of manually adjustments)&#xD;
&#xD;
      Fluids will be given as goal directed fluid therapy in order to maintain stroke volume&#xD;
      variation below 13% (hospital guidelines).&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">September 25, 2020</start_date>
  <completion_date type="Actual">October 30, 2020</completion_date>
  <primary_completion_date type="Actual">October 30, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>Single prospective pilot study (12 patients)</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Percentage of case Time in hypotension (SAP &lt;117 mmHg)</measure>
    <time_frame>At postoperative day 1</time_frame>
    <description>The primary outcome will be the percentage of case time in predefined SAP target (SAP of 130 mmHg -10 % = 117 mmHg)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Amount of vasopressors received</measure>
    <time_frame>At postoperative day 1</time_frame>
    <description>Amount of vasopressors received (norepinephrine)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of vasopressors infusion rate modifications</measure>
    <time_frame>At postoperative day 1</time_frame>
    <description>Number of vasopressors infusion rate modifications</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of case time with a MAP &lt; 65 mmHg</measure>
    <time_frame>At postoperative day 1</time_frame>
    <description>Percentage of case time with a MAP &lt; 65 mmHg</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">12</enrollment>
  <condition>Cardiovascular Diseases</condition>
  <arm_group>
    <arm_group_label>Closed-loop</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Closed-loop administration of norepinephrine</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Closed-loop vasopressor</intervention_name>
    <description>The system will adjust the norepineprhine infusion rate based on a target SAP of 130 mmHg in 20 patients</description>
    <arm_group_label>Closed-loop</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Adult patients (age of &gt;17)&#xD;
&#xD;
          -  Elective high-risk abdominal surgery&#xD;
&#xD;
          -  Patients with an arterial line and in whom a goal directed fluid therapy protocol is&#xD;
             applied manually (administration of fluid bolus to maintain a stroke volume variation&#xD;
             &lt; 13%)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Atrial Fibrillation&#xD;
&#xD;
          -  Pregnancy&#xD;
&#xD;
          -  Subjects without the capacity to give informed consent&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>99 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alexandre Joosten, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>ERASME</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Erasme</name>
      <address>
        <city>Brussels</city>
        <zip>1070</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>April 19, 2020</study_first_submitted>
  <study_first_submitted_qc>April 21, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">April 22, 2020</study_first_posted>
  <last_update_submitted>March 11, 2021</last_update_submitted>
  <last_update_submitted_qc>March 11, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 15, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Erasme University Hospital</investigator_affiliation>
    <investigator_full_name>Alexandre Joosten, MD PhD</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cardiovascular Diseases</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vasoconstrictor Agents</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

